BBB Foods Inc.
TBBB · Consumer Defensive
$49.90
Φόρτωση γραφήματος…
Νέα
Τελευταίοι τίτλοι για αυτή τη μετοχή
BBB Foods Shows a Net Loss but Its Cash Flow Surged. Here's How to Read an Insider's Trade Before Last Week's Earnings
BBB Foods director Sami Gabriel Khouri sold 14,101 shares (~$573,500) on August 7 to cover tax withholding from exercised stock options. The sale is non-discretionary and carries no investment signal. Meanwhile, BBB Foods reported strong Q2 results with 39% revenue growth to 26 billion pesos, 20% same-store sales lift, and 155 net new store openings. Despite a reported net loss (driven by non-cash charges), operating cash flow surged, and the company is funding aggressive expansion without increasing debt.
You Can't Invest In Trader Joe's, But This Mexican Grocery Stock With the Same Business Model Might Be Even Better
BBB Foods (TBBB), a Mexican grocery chain operating Tiendas 3B stores, is rapidly expanding with a business model similar to Trader Joe's and Aldi. The company reported 20% same-store sales growth in Q2 2026, reaching 3,624 stores with plans to quadruple its footprint. The stock has nearly tripled since its 2024 IPO, with a fair price-to-sales ratio of 1.
Why BBB Foods Stock Is Skyrocketing Higher Today
BBB Foods (TBBB) stock surged 16.73% after reporting Q2 earnings with 39% sales growth and 44% adjusted EBITDA growth, despite a larger-than-expected net loss. The Mexican hard-discount grocer, operating 3,624 Tiendas 3B stores, continues hypergrowth expansion with management targeting 14,000 stores long-term. The company is self-funding growth through strong operating cash flow despite opening nearly 600 new stores and a 20% share count increase.
Stanley Druckenmiller's Portfolio Skips Megacap Tech Almost Entirely. Here's What He's Buying Instead.
Billionaire investor Stanley Druckenmiller has dramatically reduced his exposure to megacap tech stocks, holding only Amazon as a minor position (0.32%) among the Magnificent Seven and completely exiting Alphabet. Instead, he's concentrating his $3 billion portfolio in biotech (Natera at 21%), semiconductors (Taiwan Semiconductor at 5.7%), and emerging markets, while adding positions in semiconductor suppliers like Broadcom, Micron, and STMicroelectronics.